• Metabolic complications, including obesity, are frequent in acute lymphoblastic leukemia (ALL) survivors treated with cranial radiotherapy (CRT) in childhood • Such complications are potentially mediated by the hypothalamus (HT), a regulator of energy expenditure • Childhood onset (CO) Craniopharyngioma (CP) survivors without HT involvement are often spared gross obesity problems • Magnetic resonance diffusion tensor imaging (DTI) provides information on the tissue microstructure of the brain as quantified by its parameters fractional anisotrophy (FA), mean diffusivity (MD), axial diffusivity (AD), radial diffusivity (RD)
Background
• Metabolic complications, including obesity, are frequent in acute lymphoblastic leukemia (ALL) survivors treated with cranial radiotherapy (CRT) in childhood • Such complications are potentially mediated by the hypothalamus (HT), a regulator of energy expenditure • Childhood onset (CO) Craniopharyngioma (CP) survivors without HT involvement are often spared gross obesity problems • Magnetic resonance diffusion tensor imaging (DTI) provides information on the tissue microstructure of the brain as quantified by its parameters fractional anisotrophy (FA), mean diffusivity (MD), axial diffusivity (AD), radial diffusivity (RD)
Delineation of the hypothalamus Participants • 27 ALL survivors (median age 34 years (27-46 years), treated with a CRT dose of 24 Gy and on complete hormone supplementation, were investigated 34 years after diagnosis • 17 CO-CP survivors (36 years (18-49 years) with complete hormone supplementation but without HT involvement according to peroperative neurosurgical assessment • Comparisons were made to 27 age and sex matched controls regarding DTI parameters in the HT as well as for BMI, fat mass, fat free mass and waist/hip measurements Aim Since MD in the HT is reportedly increased in obese compared to non-obese subjects, we investigated DTI in the HT in these two patient populations to find out HT´s involvement in the obesity in ALL survivors No treatment is currently available for these hypothalamic problems The mainstay is tailored healthy life-style support and proper hormone replacement
